A Houston entrepreneur has created a platform that puts artists first. Photo courtesy of PickleJar

Like so many business owners, Jeff James' inspiration for his innovative new music app PickleJar, came out of sheer necessity. Sitting in a bar in the buzzy Broadway district in Nashville, Tennessee, James, a serial entrepreneur, realized there had to be a better way to tip performing musicians.

"This young girl comes through the crowd carrying a Yeti bucket asking for 20 dollars for the band," James tells CultureMap. With no cash on hand, James donated via Square. "Sixty dollars later, I had so many questions: would she remember my name? Would she remember my songs? There's gotta be a better way to do this."

James, a former radio DJ and record label veteran, started scribbling his idea for a musician tipping app on a napkin. Two years later, PickleJar was sparked, James says, because "every musician we spoke to hates the way they're paid on these apps like Venmo and Facebook."

Pushing an "artist first," mission statement, PickleJar ensures that every musician utilizing the app keeps 100 percent of the money — something unheard of when James started the process two years ago. Fans donate to musicians on the app, and in turn, get five times that tip in proprietary digital currency called Pick Coins.

"If you tip 100 dollars to a musician, you get 500 Pick Coins," explains James, "that goes to buying tickets, merch, or VIP experiences on our app." Another artist-first perk: The artist also gets 500 Pick Coins in that scenario.

With its own e-commerce platform, PickleJar allows fans to use these Pick Coins for experiences, and musicians to use them for much-needed equipment. PickleJar has partnered with Austin-based Strait Music Company, which will provide musicians with instruments and gear. Musicians can create their own wish lists so that fans can directly contribute to the desired gear.

Fittingly, the company has partnered with local venues for themed nights. Buzzy bar McIntyre's Downtown will feature a tip-worthy Texas artist every Wednesday night in its PickLounge.

PickleJar also allows musicians to livestream. "On Facebook Live, data shows that only about eight to 10 percent of an artist's audience know they're live. On top of that, Facebook takes 30 to 40 percent of the tips." With PickleJar, 100 percent of an artists fans will be notified when the artists in livestreaming.

Fans can even donate directly to a musician's nonprofit of choice, something happening now during Hurricane Ida relief efforts. Numerous artists on PickleJar are raising funds for Ida assistance, James notes. "We really believe that a 'gratitude economy' is emerging," he says. "We wanted to create the easiest way possible for fans to say thank you."

That thank-you option also means fans can send direct messages, notes, and even pictures on the app, which, James acknowledges with a chuckle, could get very interesting.

Another musician-first nuance not found on other apps: PickleJar allows for "smart" splits, so that musicians are appropriately compensated for their specific contribution. An artist who wrote songs and drove the van to a gig, for example, can be funneled a higher percentage of tips than bandmates who contributed less.

James and his Houston-based tech team are also working on a TV channel on streaming devices, dubbed PickleJar Plus.

While one might be tempted to assume PickleJar is meant for those gig-to-gig, struggling musicians, James assures that the app is meant for every level, which he breaks down accordingly:

  • "Never-evers": These folks will never get signed, but use the app to get better
  • "Got talent, not signed": Artists can use PickleJar to build audiences and crowdfund
  • "I'm signed/labeled": Here, signed artists curate setlists which can be monetized via tips
  • "Idols": These artists are already brands. "Kenny Chesney can use this to make sure every dollar goes to a nonprofit," says James. Chesney's team can watch a meter, and when donations hit a specific dollar amount, Chesney can reward fans with their favorite song."

If all this seems to point to James one day managing and representing artists, James says that idea is not entirely off. PickleJar could one day be the world's biggest independent record label, he acknowledges, by the way it allows indies to promote themselves.

"We were in a meeting and the guy says, 'you're gonna change the entertainment world forever,'" James, recalls. "We hope so. We just want to build a relationship with artists — and put them first."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”